Skip to main content
Caplight Logo









Yiwei Medical

Yiwei Medical

Private
Snellville, GeorgiaHealthcare & Life Scienceshttps://quickmindstore.com/

Last Round

Series C

May 26, 2026

Total Funding Raised

$10.07M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Yiwei Medical is a medical technology company that develops AI-powered diagnostic and rehabilitation solutions for brain diseases, including Alzheimer's and stroke.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, AR/VR Experiences, Mental Health

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

medical AIAI diagnosticsCNS diseasemedical imagingintracranial hemorrhagestroke detectioncognitive rehabilitationVR therapyclinical decision supportradiology AIdigital healthmedtechAI triagebrain healthSaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Yiwei Medical Comparables

Compare Yiwei Medical with similar companies based on industry and business-model similarity.

Yiwei Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Brainomix
83%
RapidAI
82%
BioMind
82%

Yiwei Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMay 26, 2026
Series B ExtensionSep 30, 2022
Series BJul 1, 2021
Series A ExtensionMar 15, 2021
Series AJul 5, 2019
Pre Seed
May 17, 2018

Yiwei Medical Investors

Notable investors and investment history

Yiwei Medical investors
InvestorRounds
Guangdian CapitalSeries B Extension
China VenturesSeries A Extension
Shenzhen Futian Guiding FundSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 26, 2026

    Raised Series C round with Shenzhen Futian Guiding Fund.

  • Sep 30, 2022

    Guangdian Capital participated in the round.

Yiwei Medical Filings

Explore SEC and related filing metadata, where available.

Yiwei Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Yiwei Medical's valuation, stock price, and market status.

Is Yiwei Medical a public or private company?

Yiwei Medical is a private company.

What is the current stock price of Yiwei Medical?

Yiwei Medical is a private company with no public stock price. Caplight tracks Yiwei Medical's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Yiwei Medical worth (valuation)?

Valuation information for Yiwei Medical is not publicly available.

Can I buy Yiwei Medical stock?

Yiwei Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Yiwei Medical's last funding round?

Yiwei Medical's most recent funding round was Series C on May 26, 2026.

Who are the main investors in Yiwei Medical?

Key investors in Yiwei Medical include China Ventures.

Will Yiwei Medical IPO soon?

No public IPO plans have been announced for Yiwei Medical.

How can I track Yiwei Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Yiwei Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSnellville, Georgia
Employee Range2
Year Founded2017
Last FundingMay 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?